Skip to content

Search Results for: "brca"

Showing 101-110 of 181 results for "brca"

Search Again

Read more about FDA Approves Olaparib for Ovarian Cancer

FDA Approves Olaparib for Ovarian Cancer

(December 19, 2014) The U.S. Food and Drug Administration (FDA) has approved AstraZeneca’s Olaparib (Lynparza) for advanced, BRCA-mutated ovarian cancer, the first approval of a drug in the PARP (poly...
Read more about What is Lynch Syndrome?

What is Lynch Syndrome?

Inherited gene mutations, such as BRCA 1 and BRCA 2, can increase the risk of developing ovarian cancer as well as uterine (endometrial) cancer. Some of these mutations, which affect...
Read more about OCRA Awards Prizes in Ovarian Cancer Research

OCRA Awards Prizes in Ovarian Cancer Research

...for patients. Dr. Adams initial project, Development of Combination Therapy with PARP-inhibitors and Immunomodulation for BRCA-1 Epithelial Ovarian Cancer, explored a combination of PARP-inhibitor and immunotherapy to target CTLA-4 antibodies...

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.